199 related articles for article (PubMed ID: 8971305)
21. A United States multicentre trial of dual and proton pump inhibitor-based triple therapies for Helicobacter pylori.
Laine L; Frantz JE; Baker A; Neil GA
Aliment Pharmacol Ther; 1997 Oct; 11(5):913-7. PubMed ID: 9354200
[TBL] [Abstract][Full Text] [Related]
22. Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study.
Pilotto A; Franceschi M; Rassu M; Leandro G; Bozzola L; Furlan F; Di Mario F
Dig Liver Dis; 2000 Nov; 32(8):667-72. PubMed ID: 11142574
[TBL] [Abstract][Full Text] [Related]
23. Cure of Helicobacter pylori infection by omeprazole-clarithromycin-based therapy in non-human primates.
Dubois A; Berg DE; Fiala N; Heman-Ackah LM; Perez-Perez GI; Blaser MJ
J Gastroenterol; 1998 Feb; 33(1):18-22. PubMed ID: 9497216
[TBL] [Abstract][Full Text] [Related]
24. Rapid improvement of symptomatology with pantoprazole, amoxycillin and metronidazole in Helicobacter pylori-positive duodenal ulcer patients.
Pilotto A; Leandro G; Franceschi M; Bierti L; Di Battista R; Notarbartolo A; Pisciotta G; Grassi A; Crestani B; Tafner G; Michelagnoli S; Garotta F
Hepatogastroenterology; 1999; 46(25):245-51. PubMed ID: 10228801
[TBL] [Abstract][Full Text] [Related]
25. 2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study.
Paoluzi P; Iacopini F; Crispino P; Nardi F; Bella A; Rivera M; Rossi P; Gurnari M; Caracciolo F; Zippi M; Pica R
Helicobacter; 2006 Dec; 11(6):562-8. PubMed ID: 17083378
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic options after failed Helicobacter pylori eradication therapy.
van der Hulst RW; Weel JF; van der Ende A; ten Kate FJ; Dankert J; Tytgat GN
Am J Gastroenterol; 1996 Nov; 91(11):2333-7. PubMed ID: 8931413
[TBL] [Abstract][Full Text] [Related]
27. Triple, standard quadruple and ampicillin-sulbactam-based quadruple therapies for H. pylori eradication: a comparative three-armed randomized clinical trial.
Mirbagheri SA; Hasibi M; Abouzari M; Rashidi A
World J Gastroenterol; 2006 Aug; 12(30):4888-91. PubMed ID: 16937475
[TBL] [Abstract][Full Text] [Related]
28. Cure of Helicobacter pylori infection and healing of duodenal ulcer: comparison of pantoprazole-based one-week modified triple therapy versus two-week dual therapy. The International Pantoprazole HP Study Group.
Adamek RJ; Bethke TD
Am J Gastroenterol; 1998 Oct; 93(10):1919-24. PubMed ID: 9772056
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication.
Ellenrieder V; Boeck W; Richter C; Marre R; Adler G; Glasbrenner B
Scand J Gastroenterol; 1999 Aug; 34(8):750-6. PubMed ID: 10499474
[TBL] [Abstract][Full Text] [Related]
30. Dual versus triple therapy: comparison of five antibiotic regimens for eradication of Helicobacter pylori in a prospective, randomized study.
Kirstein FW; Epple HJ; Bojarski C; Victor L; Fromm M; Riecken EO; Schulzke JD
Z Gastroenterol; 1998 Sep; 36(9):803-9. PubMed ID: 9795409
[TBL] [Abstract][Full Text] [Related]
31. Triple therapy with omeprazole, amoxicillin and clarithromycin is effective against Helicobacter pylori infection in gastric ulcer patients as well as in duodenal ulcer patients. Results of a randomized controlled trial in Japan.
Habu Y; Mizuno S; Hirano S; Kiyota K; Inokuchi H; Kimoto K; Nakajima M; Kawai K
Digestion; 1998; 59(4):321-5. PubMed ID: 9693202
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of short-term low-dose triple therapy for the eradication of Helicobacter pylori by factorial design in a randomized, double-blind, controlled study.
Bazzoli F; Zagari M; Pozzato P; Varoli O; Fossi S; Ricciardiello L; Alampi G; Nicolini G; Sottili S; Simoni P; Roda A; Roda E
Aliment Pharmacol Ther; 1998 May; 12(5):439-45. PubMed ID: 9663723
[TBL] [Abstract][Full Text] [Related]
33. Metronidazole, ranitidine and clarithromycin combination for treatment of Helicobacter pylori infection (modified Bazzoli's triple therapy).
Yousfi MM; El-Zimaity HM; Cole RA; Genta RM; Graham DY
Aliment Pharmacol Ther; 1996 Feb; 10(1):119-22. PubMed ID: 8871452
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
35. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
[TBL] [Abstract][Full Text] [Related]
36. Unhealed duodenal ulcers despite Helicobacter pylori eradication.
Gisbert JP; Boixeda D; Martín De Argila C; Alvarez Baleriola I; Abraira V; García Plaza A
Scand J Gastroenterol; 1997 Jul; 32(7):643-50. PubMed ID: 9246702
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of omeprazole plus two antimicrobials for the eradication of Helicobacter pylori in a Turkish population.
Uygun A; Ates Y; Erdil A; Kadayifci A; Cetin C; Gulsen M; Karaeren N; Dagalp K
Clin Ther; 1999 Sep; 21(9):1539-48. PubMed ID: 10509849
[TBL] [Abstract][Full Text] [Related]
38. Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study).
Treiber G; Wittig J; Ammon S; Walker S; van Doorn LJ; Klotz U
Arch Intern Med; 2002 Jan; 162(2):153-60. PubMed ID: 11802748
[TBL] [Abstract][Full Text] [Related]
39. A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: a prospective randomized 1-yr follow-up study.
Lerang F; Moum B; Ragnhildstveit E; Haug JB; Hauge T; Tolås P; Aubert E; Henriksen M; Efskind PS; Nicolaysen K; Søberg T; Odegaard A; Berge T
Am J Gastroenterol; 1997 Apr; 92(4):653-8. PubMed ID: 9128317
[TBL] [Abstract][Full Text] [Related]
40. Short-term low-dose triple therapy with azithromycin, metronidazole and lansoprazole appears highly effective for the eradication of Helicobacter pylori.
Caselli M; Trevisani L; Tursi A; Sartori S; Ruina M; Luzzi I; Gaudenzi P; Alvisi V; Gasbarrini G
Eur J Gastroenterol Hepatol; 1997 Jan; 9(1):45-8. PubMed ID: 9031898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
